Reply to: "Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B"

被引：0
|
作者：
Papatheodoridis, George
Sypsa, Vana
Lampertico, Pietro
机构：
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 74卷 / 01期
关键词：
D O I：
10.1016/j.jhep.2020.09.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：246 / 247
页数：3
相关论文
共 50 条
  • [1] Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
    Papatheodoridis, George, V
    Dalekos, George N.
    Idilman, Ramazan
    Sypsa, Vana
    Van Boemmel, Florian
    Buti, Maria
    Calleja, Jose Luis
    Goulis, John
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Papatheodoridi, Margarita
    Gatselis, Nikolaos
    Veelken, Rhea
    Lopez-Gomez, Marta
    Hansen, Bettina E.
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, John
    Galanis, Kostas
    Yurdaydin, Cihan
    Esteban, Rafael
    Janssen, Harry L. A.
    Berg, Thomas
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2020, 73 (05) : 1037 - 1045
  • [2] Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
    Wen, Zhili
    Feng, Yuliang
    Yan, Xiaohua
    JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 245 - 246
  • [3] SIMILAR RISK OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT DURING LONG-TERM ENTECAVIR (ETV) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Sypsa, Vana
    van Boemmel, Florian
    Buti, Maria
    Luis Calleja, Jose
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Papatheodoridi, Margarita
    Gatselis, Nikolaos K.
    Keskin, Onur
    Veelken, Rhea
    Lopez Gomez, Marta
    Hansen, Bettina E.
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Jiannis
    Galanis, Kostas
    Idilman, Ramazan
    Esteban-Mur, Rafael
    Janssen, Harry L. A.
    Berg, Thomas
    Lampertico, Pietro
    HEPATOLOGY, 2019, 70 : 286A - 287A
  • [4] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B Reply
    Tseng, Cheng-Hao
    Hsu, Yao-Chun
    Nguyen, Mindie H.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 88
  • [5] Hepatocellular Carcinoma Incidence In Chronic Hepatitis B Patients Under Long-Term Treatment With Entecavir And Tenofovir
    Cardoso, Helder
    Gaspar, Rui
    Silva, Marco
    Vale, Ana
    Macedo, Guilherme
    HEPATOLOGY, 2015, 62 : 961A - 961A
  • [6] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B Reply
    Choi, Jonggi
    Ko, Min Jung
    Lim, Young-Suk
    JAMA ONCOLOGY, 2019, 5 (06) : 916 - 917
  • [7] ALT Levels and Risk of Hepatocellular Carcinoma (HCC) in Caucasian Chronic Hepatitis B (CHB) Patients Under Long-Term Therapy with Entecavir (ETV) or Tenofovir Disoproxil Fumarate (TDF)
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Sypsa, Vana
    van Bommel, Florian
    Buti, Maria
    Luis Calleja, Jose
    Chi, Heng
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Siakavellas, Spyros
    Keskin, Onur
    Veelken, Rhea
    Lopez-Gomez, Marta
    Hansen, Bettina E.
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Ioannis
    Galanis, Kostas
    Idilman, Ramazan
    Esteban, Rafael
    Janssen, Harry L. A.
    Berg, Thomas
    Lampertico, Pietro
    HEPATOLOGY, 2018, 68 : 162A - 163A
  • [8] Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Buti, Maria
    Goulis, John
    Arends, Pauline
    Sypsa, Vana
    Manolakopoulos, Spilios
    Mangia, Giampaolo
    Gatselis, Nikolaos
    Keskin, Onur
    Savvidou, Savvoula
    Hansen, Bettina E.
    Papaioannou, Christos
    Galanis, Kostantinos
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L. A.
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2015, 62 (02) : 363 - 370
  • [9] Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Lee, Han Ah
    Seo, Yeon Seok
    Kim, Seung Up
    GASTROENTEROLOGY, 2020, 158 (08) : 2310 - 2311
  • [10] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir? Reply
    Yip, Terry Cheuk-Fung
    Wong, Grace Lai-Hung
    GASTROENTEROLOGY, 2020, 158 (08) : 2312 - 2313
12345